Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma

MED12 exon 2 mutations are common in uterine leiomyomas from South African patients

(2015) Netta Mäkinen et al.   Oncotarget

MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma

(2014) Elizabeth Bertsch et al.   MODERN PATHOLOGY

Cell Cycle Regulatory Markers in Uterine Atypical Leiomyoma and Leiomyosarcoma

(2013) Anne M. Mills et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Atypical Leiomyomas of the Uterus

(2013) Amy Ly et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

MED12 exon 2 mutations in histopathological uterine leiomyoma variants

(2013) Netta Mäkinen et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity

(2013) Marieke A. de Graaff et al.   HUMAN PATHOLOGY

MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors

(2013) Katherine E. Schwetye et al.   HUMAN PATHOLOGY

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

(2012) K Kämpjärvi et al.   BRITISH JOURNAL OF CANCER

Recent developments in uterine mesenchymal neoplasms

(2012) Sarah Chiang et al.   HISTOPATHOLOGY

Prevalence ofMED12mutations in uterine and extrauterine smooth muscle tumours

(2012) Akiko Matsubara et al.   HISTOPATHOLOGY

Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors

(2012) Eun Mi Je et al.   INTERNATIONAL JOURNAL OF CANCER

MED12 mutations in uterine fibroids-their relationship to cytogenetic subgroups

(2012) Dominique Nadine Markowski et al.   INTERNATIONAL JOURNAL OF CANCER

Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization

(2012) Mohammad Raish et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MED12 mutations in leiomyosarcoma and extrauterine leiomyoma

(2012) Gloria Ravegnini et al.   MODERN PATHOLOGY

Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas

(2012) Megan M. McGuire et al.   PLoS One

MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors

(2012) Gaëlle Pérot et al.   PLoS One

High Quality Genomic Copy Number Data from Archival Formalin-Fixed Paraffin-Embedded Leiomyosarcoma: Optimisation of Universal Linkage System Labelling

(2012) Abdulazeez Salawu et al.   PLoS One

MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas

(2011) N. Makinen et al.   SCIENCE

A Differentiation-Based MicroRNA Signature Identifies Leiomyosarcoma as a Mesenchymal Stem Cell-Related Malignancy

(2010) Laura S. Danielson et al.   AMERICAN JOURNAL OF PATHOLOGY

Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis

(2010) M. Ito et al.   CLINICAL CANCER RESEARCH

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

(2010) Shinichi Yachida et al.   NATURE

Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas

(2009) Khush R Mittal et al.   MODERN PATHOLOGY